Why Revenue Cycle Management Systems Fall Behind—and How to Modernize Them
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025
Understanding the 2024 CLFS update—and the changes that are still to come.
An overview of likely lab audit targets for the coming year, and how laboratories can ensure they’re prepared.
In terms of Medicare coverage, 2023 is shaping up to be a fruitful year—here are five of the most significant approvals so far.
Increasing medical and consumer debt is likely to get worse, meaning billing and collections may get even tougher for labs.
Agency’s annual report to Congress concludes that providers are doing just fine and don’t need a big bump in pay at this time.
The health plan issued a new policy expanding coverage of molecular genetic tests for personalized cancer diagnosis, prognosis, and treatment.
Here’s an approach to ensure your lab patients have the most positive financial experience possible.
Congress fails to include SALSA in the omnibus federal government spending bill passed at the end of 2022, but delays PAMA price cuts once again.
Automating travel and expense significantly improves performance, but adding mobility takes such improvements to a much higher level.